KLP Kapitalforvaltning AS Takes $2.01 Million Position in Chemed Co. (NYSE:CHE)

KLP Kapitalforvaltning AS purchased a new stake in Chemed Co. (NYSE:CHE - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 3,800 shares of the company's stock, valued at approximately $2,013,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CHE. UMB Bank n.a. grew its holdings in Chemed by 300.0% during the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after buying an additional 39 shares in the last quarter. Atala Financial Inc purchased a new position in Chemed during the fourth quarter valued at approximately $29,000. CBIZ Investment Advisory Services LLC grew its stake in Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after acquiring an additional 22 shares in the last quarter. Trust Co. of Vermont purchased a new stake in Chemed in the 4th quarter worth approximately $34,000. Finally, Tortoise Investment Management LLC lifted its stake in Chemed by 77.3% in the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock worth $41,000 after purchasing an additional 34 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of the company's stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $615.33, for a total value of $615,330.00. Following the completion of the sale, the chief executive officer now owns 101,679 shares of the company's stock, valued at $62,566,139.07. This represents a 0.97 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 3.32% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

CHE has been the topic of a number of recent analyst reports. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada upped their target price on Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a research note on Friday, March 14th.

Chemed Stock Performance

Chemed stock traded up $2.82 during mid-day trading on Tuesday, hitting $618.14. 260,403 shares of the company traded hands, compared to its average volume of 94,493. Chemed Co. has a one year low of $512.12 and a one year high of $639.61. The stock has a market cap of $9.05 billion, a price-to-earnings ratio of 31.23, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43. The stock has a fifty day moving average price of $576.54 and a 200-day moving average price of $567.29.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were paid a $0.50 dividend. The ex-dividend date was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a yield of 0.32%. Chemed's dividend payout ratio is presently 10.05%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.